Σοφ. Βενιζέλου 114, Χαλάνδρι - Τ.: 2106719422
The US Food and Drug Administration (FDA) has approved tirzepatide for chronic weight management in adults with obesity or overweight. Eli Lilly & Company will market tirzepatide injections for weight management under the trade name Zepbound. It was approved in May 2022 for treating type 2 diabetes. The new indication is for adults with either…
DetailsRod Tucker 19 June 2023 With increasing evidence that cannabis use is associated with adverse cardiovascular effects, questions are undoubtedly being asked about the safety of the drug for medical uses. Rod Tucker investigates. Cardiovascular risks For several states in the US and many other countries such as Canada, use of recreational cannabis has been…
DetailsRod Tucker 20 October 2023 Air pollution contains particulate matter that can carry antibiotic resistance genes, which have been found to accelerate microbial threats to human health. Here, Rod Tucker considers the extent to which air pollution could serve as a primary vector and driving force behind the increasing levels of global antibiotic resistance.
DetailsAir pollution contains particulate matter that can carry antibiotic resistance genes, which have been found to accelerate microbial threats to human health. Here, Rod Tucker considers the extent to which air pollution could serve as a primary vector and driving force behind the increasing levels of global antibiotic resistance.
The potential for detection of colorectal cancer based on an analysis of the variability in a patient‘s gut microbiome has been highlighted in a study presented at United European Gastroenterology (UEG) Week. The findings come from the Dutch microbiome project, which is a large-scale studying involving 8,208 participants. Researchers analysed the gut microbiome of those…
DetailsIncident heart failure risk is significantly increased after an acute COVID-19 infection and directly influenced by age and prior hypertension Heart failure risk has been found to be significantly elevated within 9 months of an acute COVID-19 infection and directly related to both age and a previous history of hypertension, according to a systematic review…
DetailsWhile supplementing with vitamin D may well help to reduce the risk of developing a Covid-19 infection and the subsequent Covid-related adverse outcomes, the role of the vitamin in long Covid is more uncertain. Although the recent JCEM study highlighted that low vitamin D levels were associated with long Covid, there is an urgent need…
DetailsMetformin use by overweight or obese patients reduces the risk of developing long Covid by around 41%, according to the findings of a recent randomised, placebo-controlled trial. Published in The Lancet Infectious Diseases, the study followed up on previous research which sought to determine whether the use of metformin, ivermectin or fluvoxamine prevented the primary…
DetailsA previous interim analysis concluded that the incidence of selected serious outcomes was not significantly higher one to 21 days post-vaccination compared with 22-42 days post-vaccination for mRNA Covid-19 vaccines. Moreover, a further analysis indicated a low incidence of myocarditis and pericarditis among individuals persons aged five to 39 years. While these data are reassuring,…
DetailsA previous interim analysis concluded that the incidence of selected serious outcomes was not significantly higher one to 21 days post-vaccination compared with 22-42 days post-vaccination for mRNA Covid-19 vaccines. Moreover, a further analysis indicated a low incidence of myocarditis and pericarditis among individuals persons aged five to 39 years. While these data are reassuring,…
Details